JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taki, J.
Right arrow Articles by Strauss, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taki, J.
Right arrow Articles by Strauss, H. W.
Journal of Nuclear Medicine Vol. 45 No. 9 1536-1541
© 2004 by Society of Nuclear Medicine


Basic Science Investigations

Detection of Cardiomyocyte Death in a Rat Model of Ischemia and Reperfusion Using 99mTc-Labeled Annexin V

Junichi Taki, MD, PhD1, Takahiro Higuchi, MD, PhD1, Atsuhiro Kawashima, MD, PhD2, Jonathan F. Tait, PhD, MD3, Seigo Kinuya, MD, PhD1, Akira Muramori, MD, PhD1, Ichiro Matsunari, MD, PhD4, Kenichi Nakajima, MD, PhD1, Norihisa Tonami, MD, PhD1 and H. William Strauss, MD5

1 Department of Biotracer Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
2 Department of Molecular and Cellular Pathology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan
3 Department of Laboratory Medicine, University of Washington, Seattle, Washington
4 Medical and Pharmacological Research Center Foundation, Hakui, Japan
5 Division of Nuclear Medicine, Department of Radiology, Memorial Sloan-Kettering Hospital, New York, New York

There is increasing evidence that cell death after myocardial ischemia and reperfusion may begin as apoptosis rather than necrosis. To determine the time course, location, and extent of this process, we studied groups of rats after a 20-min interval of coronary occlusion and reperfusion. Methods: After thoracotomy, the left coronary artery was occluded for 20 min. After release and before study, groups of animals were allowed to recover for various intervals: 0.5 h (n = 6), 1.5 h (n = 7), 6 h (n = 7), 1 d (n = 8), 3 d (n = 8), or 2 wk (n = 5). At the time of study, the rats were injected with 99mTc-annexin V (80–150 MBq). One hour later, to verify the area at risk, 201Tl (0.74 MBq) was injected intravenously just after the left coronary artery reocclusion and the rats were sacrificed 1 min later. Dual-tracer autoradiography was performed to assess 99mTc-annexin V uptake and the area at risk. Results: Extensive 99mTc-annexin V uptake was observed in the mid myocardium after 0.5–1.5 h of reperfusion. The area of annexin uptake had expanded in the subendocardial and subepicardial layers at 6 h after reperfusion and then gradually lessened over 3 d. At 0.5 and 1.5 h of reperfusion, 99mTc-annexin V uptake ratios were 7.36 ± 2.95 and 6.34 ± 2.24 (mean ± SD), respectively. The uptake ratios gradually decreased at 6 h, 1 d, 3 d, and 2 wk after reperfusion (4.65 ± 1.93, 3.27 ± 0.92 [P < 0.01 vs. 0.5 h], 1.84 ± 0.55 [P < 0.001 vs. 0.5 h, P < 0.005 vs. 1.5 h], and 1.65 ± 0.31 [P < 0.001 vs. 0.5 h, P < 0.005 vs. 1.5 h], respectively). Conclusion: These data indicate that annexin binding commences soon after ischemia and reperfusion in the mid myocardium within the area at risk and expands to include the subendocardial and subepicardial layers at 6 h after reperfusion, followed by gradual reduction of activity over 3 d.

Key Words: 99mTc-annexin V • ischemia • reperfusion • apoptosis


Related articles in JNM:

THIS MONTH IN JNM

JNM 2004 45: 8A-9A. [Full Text]  



This article has been cited by other articles:


Home page
JNMHome page
T. Doue, K. Ohtsuki, K. Ogawa, M. Ueda, A. Azuma, H. Saji, H. W. Strauss, and H. Matsubara
Cardioprotective Effects of Erythropoietin in Rats Subjected to Ischemia-Reperfusion Injury: Assessment of Infarct Size with 99mTc-Annexin V
J. Nucl. Med., October 1, 2008; 49(10): 1694 - 1700.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Higuchi, F. M. Bengel, S. Seidl, P. Watzlowik, H. Kessler, R. Hegenloh, S. Reder, S. G. Nekolla, H. J. Wester, and M. Schwaiger
Assessment of {alpha}v{beta}3 integrin expression after myocardial infarction by positron emission tomography
Cardiovasc Res, May 1, 2008; 78(2): 395 - 403.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
J. Taki, T. Higuchi, A. Kawashima, M. Fukuoka, D. Kayano, J. F. Tait, I. Matsunari, K. Nakajima, S. Kinuya, and H. W. Strauss
Effect of Postconditioning on Myocardial 99mTc-Annexin-V Uptake: Comparison with Ischemic Preconditioning and Caspase Inhibitor Treatment
J. Nucl. Med., August 1, 2007; 48(8): 1301 - 1307.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Higuchi, S. G. Nekolla, A. Jankaukas, A. W. Weber, M. C. Huisman, S. Reder, S. I. Ziegler, M. Schwaiger, and F. M. Bengel
Characterization of Normal and Infarcted Rat Myocardium Using a Combination of Small-Animal PET and Clinical MRI
J. Nucl. Med., February 1, 2007; 48(2): 288 - 294.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Zhao, X. Zhu, S. Ji, J. Zhou, K. S. Ozker, W. Fang, R. C. Molthen, and R. S. Hellman
99mTc-Labeled C2A Domain of Synaptotagmin I as a Target-Specific Molecular Probe for Noninvasive Imaging of Acute Myocardial Infarction
J. Nucl. Med., August 1, 2006; 47(8): 1367 - 1374.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. H. Boersma, B. L.J.H. Kietselaer, L. M.L. Stolk, A. Bennaghmouch, L. Hofstra, J. Narula, G. A.K. Heidendal, and C. P.M. Reutelingsperger
Past, Present, and Future of Annexin A5: From Protein Discovery to Clinical Applications
J. Nucl. Med., December 1, 2005; 46(12): 2035 - 2050.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N S Kleiman and H D White
The declining prevalence of ST elevation myocardial infarction in patients presenting with acute coronary syndromes
Heart, September 1, 2005; 91(9): 1121 - 1123.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.